A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM. Gironi, Gianvito Martino, Mauro Zaffaroni et al.|Multiple Sclerosis Journal|2008Cited by 96
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 PneumoniaFrancesco Menichetti, Alessandro Mazzoni, Patrizia Popoli et al.|JAMA Network Open|2021Cited by 69